首页|异氟烷抑制铁死亡改善心肌缺血再灌注损伤的作用研究

异氟烷抑制铁死亡改善心肌缺血再灌注损伤的作用研究

扫码查看
目的:探讨异氟烷对心肌缺血再灌注(MI/R)损伤的保护作用,并从铁死亡角度阐明其可能的作用机制。方法:动物水平以健康雄性SD大鼠为研究对象,细胞水平以H9C2心肌细胞为研究对象,实验分为正常组、模型组、异氟烷组、模型+异氟烷组和模型+铁死亡抑制剂(Ferrostatin-1)组。采用氯化硝基四氮唑蓝(NBT)染色观察心肌组织梗死面积;HE染色观察心肌组织形态学变化;CCK-8法测定心肌细胞活力;酶联免疫吸附(ELISA)法测定乳酸脱氢酶(LDH)和肌酸激酶同工酶(CK-MB)含量;试剂盒检测心肌组织或H9C2细胞中活性氧(ROS)、丙二醛(MDA)、Fe2+含量,以及超氧化物歧化酶(SOD)和谷胱甘肽过氧化物酶(GSH-Px)活性。Western blot和免疫荧光检测各组大鼠心肌组织或细胞中溶质载体家族7成员11(SLC7A11),谷胱甘肽过氧化酶4(GPX4)和核转录因子E2相关因子2(Nrf2)蛋白表达。结果:与正常组相比,模型组心肌梗死面积增大(P<0。01),心肌细胞活性降低(P<0。01),LDH和CK-MB含量明显增加(P<0。01),心肌组织或细胞中ROS、MDA和铁离子含量增加(P<0。01),GSH-Px活性降低(P<0。01),SLC7A11、GPX4和核Nrf2蛋白表达水平降低(P<0。01)。与模型组相比,异氟烷和Ferrostatin-1组心肌梗死面积减少(P<0。01),心肌细胞活力增加(P<0。01),心肌组织或细胞中ROS、MDA和铁离子含量减少(P<0。01),GSH-Px活性增加(P<0。01),SLC7A11、GPX4和核Nrf2蛋白表达增加(P<0。01)。结论:异氟烷预处理通过激活Nrf2通路,增加SLC7A11和GPX4蛋白表达,抑制心肌细胞的铁死亡,从而发挥对缺血再灌注心肌损伤的改善作用。
Effect of isoflurane on arresting ferroptosis and improving myocardial ischemia-reperfusion injury
OBJECTIVE To explore the protective effect of isoflurane on myocardial ischemia reperfusion(MI/R)injury and elucidate its potential mechanism from the perspective of ferroptosis.METHODS Healthy male Sprague-Dawley(SD)rats were used as research subjects at animal level and H9C2 cardiomyocytes as research subjects at cellular level.They were assigned into five groups of control,model,isoflurane,model+isoflurane and model+Ferrostatin-1.Myocardial infarct area was deter-mined after nitrotetrazolium blue chloride(NBT)stain.Morphological changes in myocardial tissue were observed after hematoxylin-eosin stain.Myocardial cell viability was determined by CCK-8 method.The levels of lactate dehydrogenase(LDH)and creatine kinase isoenzyme(CK-MB)were measured by enzyme-linked immunosorbent assay(ELISA).The values of reactive oxygen species(ROS),malondialdehyde(MDA),Fe2+,superoxide dismutase(SOD)and glutathione peroxidase(GSH-Px)in myocardial tissue or H9C2 cells were detected by kits.Western blot was utilized for detecting the protein expres-sions of solute carrier family 7 member 11(SLC7A11),glutathione peroxidase 4(GPX4)and nuclear factor erythroid 2-related factor 2(Nrf2)in myocardial tissue or cells.RESULTS As compared with control group,model group had a spike in myocar-dial infarction area(P<0.01),lowered myocardial cell activity(P<0.01),sharp spike of LDH/CK-MB content(P<0.01),spikes in ROS,MDA and Fe2+in myocardial tissue or cells(P<0.01),lowered GSH-Px activity(P<0.01)and down-regulations of SLC7A11,GPX4 and nuclear Nrf2 proteins(P<0.01).As compared with model group,isoflurane and positive control groups showed declines in myocardial infarction(P<0.01),greater myocardial cell viability(P<0.01),declines in ROS,MDA and Fe2+in myocardial tissue or cells(P<0.01),greater GSH-Px activity(P<0.01)and spikes in SLC7A11,GPX4 and nuclear Nrf2 protein expression(P<0.01).CONCLUSION Pretreatment with isoflurane may activate the Nrf2 pathway,enhance the expressions of SLC7A11 and GPX4 proteins,suppress ferroptosis in myocardial cells and thus exert protec-tive effects on MI/R injury.

isofluranemyocardial ischemia reperfusion injuryferroptosisnuclear factor erythroid 2-related factor 2gluta-thione peroxidase 4

张琪瑶、秦国伟、陆顺梅、王洪新

展开 >

南京医科大学无锡医学中心,无锡市人民医院,南京医科大学附属无锡人民医院麻醉科,江苏无锡 214023

锦州医科大学心脑血管药物重点实验室,辽宁锦州 121001

异氟烷 心肌缺血再灌注 铁死亡 核转录因子E2相关因子2 谷胱甘肽过氧化酶4

国家自然科学基金

81973553

2024

中国医院药学杂志
中国药学会

中国医院药学杂志

CSTPCD北大核心
影响因子:1.198
ISSN:1001-5213
年,卷(期):2024.44(10)
  • 23